Genome Profiling

📍 Wayne, United States🗓 Founded 2014👥 5 employees💰 Last funded Oct 2016
Biotechnology🌐 genomeprofiling.com
Website LinkedIn
Genome Profiling is a functional genomics company focused on decoding the sentinel power of the immune system’s global epigenetic response to acute and chronic health conditions, and to therapeutic interventions. We're leveraging those insights to create a pipeline of novel clinical diagnostic products that deliver transformational benefits to biopharmas, clinicians, patients and payers. The Company employs proprietary chemical and machine learning methods/operations to discover blood-based, quantitative, epigenetic “fingerprints” called EpiMarkers. EpiMarkers phenotypically characterize early and disease-specific immune system activation and function by providing increased resolution of dynamic gene methylomics (activation or suppression of the immune systems functional genes) that can be translated into current clinical testing methods. Genome Profiling EpiMarkers provide dynamic and detailed insights, that classical gene-mutation based methods cannot address, to enable novel precision diagnostic tests for acute and chronic diseases and to identify novel therapeutic targets. The Company’s primary focus is to apply its critical intellectual property and a growing epigenetic profile database for the rapid discovery and controlled validation of immune system derived EpiMarkers in cancer and neurological disorders.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Genome Profiling?
Genome Profiling has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Genome Profiling last raise funding?
The most recent investment in Genome Profiling recorded on gritt.io was in October 2016.
When was Genome Profiling founded?
Genome Profiling was founded in 2014.
What industry is Genome Profiling in?
Genome Profiling operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Genome Profiling based?
Genome Profiling is headquartered in Wayne, United States.